💉🐕 Bravecto Quantum (1-Year Injectable) vs. Bravecto Chews (3-Month): 2026 Cost Comparison, Expanded Tick Coverage & The FDA Neurological Seizure Warning Every Dog Owner Must Read
In July 2025, the FDA approved something that doesn't happen often in veterinary medicine: a once-yearly flea and tick injectable. Bravecto Quantum — fluralaner in an extended-release suspension — replaced twelve monthly doses with a single in-clinic injection. Then in March 2026, the FDA expanded its label again, adding two more tick species for 12-month coverage. But here's what the marketing materials don't put on the front page: the same FDA label that approves Bravecto Quantum also states that in a US field study, 0.9% of dogs (2 out of 225) experienced seizures. The entire isoxazoline class — including every Bravecto product — carries an FDA-mandated neurological warning. This guide gives you the full picture: what Quantum actually costs vs. the chews, what the seizure warning really means, and the honest framework for choosing between them.
⚡ What's Actually New in 2026 — The March 18 Expanded Label
Original approval (July 10, 2025): Bravecto Quantum approved for 12-month control of fleas, black-legged tick (Ixodes scapularis), American dog tick (Dermacentor variabilis), brown dog tick (Rhipicephalus sanguineus); 8-month control of lone star tick (A. americanum)
March 18, 2026 expansion (BusinessWire/Merck): FDA approved two additional tick species — Asian longhorned tick (Haemaphysalis longicornis) and Gulf Coast tick (Amblyomma maculatum) — for 12-month control. These are both clinically relevant species expanding in geographic range across the US.
Why the Asian longhorned tick matters: H. longicornis has spread to 20+ US states since its first detection in New Jersey in 2017. It can transmit Theileria — a blood parasite — and can reproduce without a male (parthenogenesis), meaning infestations can grow explosively. The March 2026 label adds protection against this expanding threat.
Safety re-confirmed: Merck/Merck Animal Health: "Safety was demonstrated when dosed at 5 times the recommended dose every 4 months for a total of 6 doses." The seizure rate in the US field study: 0.9% (2/225 dogs) — described as "consistent with estimates reported in the general dog population."
🔬 The Isoxazoline Mechanism: Why This Drug Works — and Why It Carries a Seizure Warning
🧠 How Fluralaner (Isoxazoline) Works
Fluralaner belongs to the isoxazoline class — a relatively new category of parasiticides that work by blocking GABA-gated chloride channels and glutamate-gated chloride channels in the nervous systems of insects and arachnids (fleas and ticks). When a flea or tick bites a treated dog and ingests blood containing fluralaner, the drug disrupts their nerve signal transmission, causing hyperexcitation, paralysis, and death.
Why dogs can take it safely: The drug preferentially targets invertebrate receptor subtypes. Mammalian GABA receptors have a different structure, making them far less sensitive to fluralaner. This is the pharmacological basis for the drug's safety profile.
Why the neurological warning exists: "Preferentially targets" is not the same as "exclusively targets." FDA official safety communication: "This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a prior history of seizures." The mechanism for this minority of cases is not fully established — but the cross-reactivity risk in some individuals is real enough that the FDA mandated label changes across all isoxazoline products.
Bravecto Quantum's unique challenge: Unlike a chew that clears the system in 12 weeks, the injectable extended-release formulation maintains fluralaner levels for 12 months. If a dog develops an adverse neurological reaction, the drug cannot be quickly eliminated by stopping administration. This is the most important clinical consideration distinguishing Quantum from the chew forms.
⚠️ The FDA Neurological Warning — The Complete Official Picture
🚨 FDA Official Safety Communication — Isoxazoline Class (Including All Bravecto Products)
Source: U.S. FDA "Animal Drug Safety Communication: FDA Alerts Pet Owners and Veterinarians About Potential for Neurologic Adverse Events Associated with Certain Flea and Tick Products" (fda.gov)
Drugs covered: Fluralaner (Bravecto — all formulations including Quantum), afoxolaner (Nexgard), sarolaner (Simparica), lotilaner (Credelio)
What the FDA found: Post-marketing surveillance indicated that some animals receiving these drugs experienced adverse events including muscle tremors, ataxia (loss of coordination), and seizures. These events were seen "consistently across the isoxazoline class," leading the FDA to mandate new label language for all products.
Critical language on the label: "Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders."
Bravecto Quantum field study specific data (Merck, March 2026): In the US field study, 0.9% of dogs (2 out of 225) experienced seizures. Merck states this rate is "consistent with estimates reported in the general dog population" — but that context requires careful interpretation: it doesn't mean the drug didn't contribute; it means the rate didn't clearly exceed background population rates.
FDA's overall position: "These products continue to be safe and effective for the majority of animals." The FDA reviewed safety studies prior to approval and continues monitoring. The mandate for label changes was to ensure informed individual decision-making — not to signal that these drugs are broadly unsafe.
The irreversibility problem with Quantum: The FDA safety communication and label apply equally to all formulations. However, if a dog develops seizures after a Bravecto Quantum injection, the drug will continue releasing for up to 12 months. There is no reversal agent. This is a materially different risk profile from a chew that is eliminated within weeks.
💰 The 2026 Cost Comparison: Quantum vs. Chews vs. Alternatives
💉 Bravecto Quantum
Drug cost: $149–$219 per year (weight-based; national average ~$159)
Metro clinics: $179–$219
Rural clinics: $149–$169
Add vet exam fee: $45–$75 (annual wellness exam required)
Prescription handling: $8–$15
Total annual cost: ~$200–$310
Doses per year: 1 injection
Duration per dose: 12 months (fleas + 4 tick species); 8 months (lone star tick)
Administration: Vet only — subcutaneous injection; 15 mg fluralaner/kg; 0.1 mL/kg body weight; multi-dose vial
FDA approved: July 10, 2025; expanded label March 18, 2026
🦴 Bravecto Chews (3-Month)
Vet clinic price: $73–$81 per dose (all weight ranges)
Annual cost at vet: $292–$324 (4 doses)
Online retailers: $58 per chew; discount sites $37.98–$42.22
Annual cost online: $151–$232 (4 doses)
Manufacturer rebate: $25 when buying 4 doses
Total annual cost: ~$151–$324 depending on source
Doses per year: 4 chews
Duration per dose: 12 weeks (fleas + most ticks); 8 weeks (lone star tick)
Administration: Owner at home — oral chew; no vet visit required for drug delivery
FDA approved: Original approval; isoxazoline class warning on all labels
| Cost Factor | Bravecto Quantum (Yearly) | Bravecto Chews at Vet (Yearly) | Bravecto Chews Online (Yearly) |
|---|---|---|---|
| Drug cost | $149–$219 | $292–$324 | $151–$232 |
| Annual wellness exam | $45–$75 (required for prescription) | $45–$75 (standard recommendation) | $45–$75 (online script may avoid extra visits) |
| Vet visit for drug delivery | Required — injection admin by vet only | Not required — home administration | Not required — home administration |
| Missed dose risk | Eliminated — 1 dose covers 12 months | High — 4 doses/year; compliance challenge | High — 4 doses/year; compliance challenge |
| If drug reaction occurs: stop immediately | Not possible — extended release continues 12 months | Yes — next dose simply not given | Yes — next dose simply not given |
| Suitable for pill-averse dogs | Yes — injection at vet | No — must accept oral chew | No — must accept oral chew |
| True annual total (estimate) | $200–$310 | $340–$400 | $196–$307 |
💡 The cost takeaway: Bravecto Quantum at a metro clinic costs roughly the same annually as buying Bravecto Chews online — but less than chews purchased at the vet. ThePricer.org (reviewed March 2026): national average for Quantum is ~$159/year, undercutting the four-dose Bravecto Chew total of $275.96 and NexGard's six-pack at $310. The financial case for Quantum is strongest for pill-averse dogs and owners who consistently miss oral doses. For owners who reliably buy chews online at discount, the cost difference is marginal.
🕷️ Tick Coverage Comparison: What Each Product Actually Protects Against in 2026
| Tick Species | Geographic Range | Quantum Duration | Chews Duration | Why It Matters |
|---|---|---|---|---|
| Black-legged tick (I. scapularis) | Eastern US + expanding | 12 months | 12 weeks | Primary vector for Lyme disease, anaplasmosis |
| American dog tick (D. variabilis) | Eastern US, Pacific Coast | 12 months | 12 weeks | Rocky Mountain spotted fever vector |
| Brown dog tick (R. sanguineus) | Nationwide + tropical | 12 months | 12 weeks | Indoor infestations; RMSF + ehrlichiosis |
| Lone star tick (A. americanum) | Southeast/South-Central, expanding | 8 months | 8 weeks | Alpha-gal syndrome (red meat allergy in humans) |
| Asian longhorned tick (H. longicornis) ★ NEW | 20+ US states; NJ first detected 2017 | 12 months (NEW — Mar 2026) | Not on label | Theileria; parthenogenetic — explosive infestations |
| Gulf Coast tick (A. maculatum) ★ NEW | Atlantic + Gulf Coast | 12 months (NEW — Mar 2026) | Not on label | Rickettsia parkeri; expanding range |
✅ The tick coverage advantage: The March 2026 label expansion gives Bravecto Quantum protection against two tick species that the standard Bravecto Chews label does not specifically address. For dog owners in states where Asian longhorned tick has been detected (Virginia, New Jersey, Maryland, New York, Connecticut, North Carolina, Arkansas, Georgia, Kentucky, Pennsylvania, Tennessee, and others), this is a clinically meaningful difference.
🐕 Who Should (and Should NOT) Get Bravecto Quantum: The Clinical Decision Framework
| Dog Profile | Quantum: Good Choice? | Reasoning |
|---|---|---|
| Pill-averse dog who refuses chews | ✅ Strong yes | Eliminates the compliance challenge entirely; one injection per year |
| Owner with history of forgetting doses | ✅ Strong yes | Missed monthly/quarterly doses are a major cause of treatment failure; Quantum removes this risk |
| Dog in Asian longhorned tick endemic area | ✅ Yes — expanded label | Only Quantum provides FDA-confirmed 12-month protection against H. longicornis as of March 2026 |
| Dog with known history of seizures | ❌ Strong caution / avoid | FDA label: "Use with caution in dogs with a history of seizures or neurologic disorders." If seizures occur with Quantum, you cannot stop the drug for 12 months — irreversible exposure |
| Dog with any neurological disorder | ❌ Discuss carefully with vet | Same irreversibility concern; even chews carry this warning, but their elimination makes risk management much more practical |
| Owner wanting ability to stop if reaction | ❌ Quantum not appropriate | Extended-release nature means no ability to halt exposure; chews are preferable if monitoring flexibility is a priority |
| Puppy under 6 months | ❌ Not eligible | Quantum: for dogs 6 months and older; chews: 8 weeks and older (standard 3-month) or 6 months (1-month chew) |
| Dog in active flea season with immediate issue | ⚠️ Consider chews first | Quantum requires constitution (mixing two vials) and vet appointment; chews provide immediate home treatment |
| Breeding, pregnant, or lactating dog | ❌ Not evaluated | Merck/FDA: "Safety of Bravecto Quantum has not been evaluated in breeding, pregnant and lactating dogs." Adverse events reported in breeding females with standard Bravecto Chews. |
🔴 Side Effects: Quantum vs. Chews — Full Comparison
| Side Effect | Bravecto Quantum | Bravecto Chews (3-Month) | Key Difference |
|---|---|---|---|
| Lethargy / decreased energy | Yes — listed in field study | Yes — commonly reported | Similar profile |
| Decreased appetite / anorexia | Yes — field study | Yes — commonly reported | Similar profile |
| Vomiting | Yes — field study | Yes — commonly reported | Injection may bypass some GI upset |
| Diarrhea | Yes — field study | Yes — commonly reported | Similar profile |
| Elevated liver enzymes (ALT) | Yes — field study | Yes — standard Chews label | Monitor if pre-existing liver disease |
| Pruritus / itching | Yes — field study | Yes — Chews label | Similar profile |
| Injection site reaction | Possible (swelling/discomfort) | N/A — oral product | Unique to injectable route |
| Seizures / neurological signs | 0.9% in field study (2/225); FDA class warning | FDA class warning; reported post-approval | QUANTUM: irreversible 12-month exposure if seizure occurs |
| Can stop immediately if reaction | NO — extended release; 12 months | YES — simply discontinue next dose | Critical difference favoring Chews for high-risk dogs |
🚨 The irreversibility problem — stated plainly: If your dog receives a Bravecto Quantum injection and develops seizures or severe neurological signs 3 months later, you cannot stop the drug. Fluralaner will continue releasing from the subcutaneous depot for the remaining 9 months. There is no antidote. There is no reversal agent. Your vet can only manage symptoms. This is the single most important clinical factor distinguishing Quantum from all oral formulations — and it is buried in the safety data, not on the marketing materials. If you have any reason to suspect your dog may be neurologically vulnerable, the chew formulation is the safer choice precisely because it can be discontinued.
📋 Pre-Injection Checklist: Questions to Ask Before Saying Yes to Quantum
✅ Bravecto Quantum Pre-Treatment Checklist
- Seizure history: "Has my dog ever had a seizure, muscle tremor, or episode of unexplained collapse?" If yes → strong caution; discuss chews as alternative
- Neurological assessment: "Is there any history of neurological disease, spinal issues, or balance problems?" Extended-release makes any neurological vulnerability more consequential
- Liver function: Request baseline liver enzyme panel (ALT, ALP) before first injection — elevated enzymes are a listed adverse effect; important to distinguish pre-existing from drug-related
- Tick exposure pattern: Ask your vet which tick species are active in your area — if Asian longhorned or Gulf Coast ticks are present, Quantum's March 2026 expanded label is a real advantage over Chews
- Compliance history: "Have you consistently administered every dose of previous flea/tick prevention on schedule?" If no → Quantum's single annual dose eliminates the compliance gap
- Breeding status: "Is my dog breeding, pregnant, or lactating?" If yes → not evaluated; discuss alternatives
- Ask explicitly: "If my dog develops a reaction to this injection, what can we do? Can we remove or reverse the drug?" (Answer: No — ensure you understand this before consenting)
- Insurance coverage: Confirm whether adverse event treatment would be covered by your pet insurance policy if seizures or neurological signs develop months post-injection
❓ Frequently Asked Questions
❓ My dog took Bravecto Chews for 3 years with no problems. Is Quantum safe for her?
Tolerating the chew formulation for years is a reassuring sign, but it is not a guarantee of equivalent safety with Quantum. The key pharmacological difference is elimination half-life. Bravecto Chews clear the system in approximately 12 weeks. Quantum maintains drug levels for 12 months. If your dog has an idiosyncratic neurological sensitivity to fluralaner that only manifests at sustained higher blood levels over time, the chew formulation might never reveal it while Quantum could. For dogs with a clean 3-year history on Chews and no neurological concerns, the risk is likely low — but the informed consent discussion about irreversibility is still important. Always share her full history with your vet before switching.
❓ The field study says only 2 dogs out of 225 had seizures — that's less than 1%. Should I really be worried?
Context matters enormously here. Merck describes the 0.9% rate as "consistent with estimates reported in the general dog population" — suggesting it may not represent a drug-attributable risk above baseline. However, two important caveats apply. First, 225 dogs is a relatively small clinical study population; real-world post-market surveillance at scale will provide more definitive numbers. Second, the population seizure rate argument doesn't address individual risk — if your specific dog is in the vulnerable minority, the population-level statistic is irrelevant to your outcome. The FDA's position is that the drug is safe for the majority of animals; the label warning exists to protect the minority who may be vulnerable.
❓ Is Bravecto Quantum cheaper than buying Bravecto Chews every 3 months?
At the vet: yes. ThePricer.org (reviewed March 2026): Quantum's national average is approximately $159/year versus $275.96 for four Bravecto Chew doses at the vet. However, if you purchase Bravecto Chews online at discount retailer prices ($37.98–$42.22/dose at sites like BudgetVetCare), the annual cost ($151–$168) is comparable to or lower than Quantum. The full cost picture also includes the vet exam fee for Quantum administration ($45–$75), which is required. For owners who reliably buy Chews online at the lowest prices, the cost difference is negligible. For owners who consistently buy from the vet, Quantum is meaningfully cheaper per year.
❓ Can the Bravecto Quantum injection be given at home, or does it always require a vet visit?
Always a vet visit — no exceptions under current FDA approval. GoodRx: "Your veterinarian will determine the correct dosage for your dog." The Merck Animal Health prescribing information confirms this is a prescription product administered by a licensed veterinarian. The injectable suspension requires mixing of two vials prior to administration, and the dose (15 mg fluralaner/kg body weight; 0.1 mL/kg) is drawn precisely from a multi-dose vial. Unlike insulin injections which pet owners learn to give at home, there is currently no pathway for owner-administered Quantum. An annual exam is typically required to maintain the prescription relationship (VCPR).
❓ My dog lives near a lake in New Jersey where they've found Asian longhorned ticks. Does Quantum make more sense than Chews now?
The March 2026 expanded label makes Quantum meaningfully stronger for your specific situation. Bravecto Chews' current label does not include FDA-confirmed coverage for H. longicornis (Asian longhorned tick). Quantum's updated label explicitly covers this species for 12 months. New Jersey was where H. longicornis was first detected in the US in 2017 and remains one of the highest-density states for this species. If your dog is regularly in areas where Asian longhorned ticks are present, Quantum's expanded coverage is a real clinical advantage — provided your dog has no neurological history that makes the irreversible formulation a concern.
Parasite Prevention Tracker · Vaccine Log · Vet Visit Reminders
Track your dog's flea and tick prevention doses, set annual injection reminders, and log any adverse reactions in real time — all in Patify.
Download Patify FreeAlso on web → patifyapp.com/straypets
Patify — A home for every paw. #PatifyFamily
#BravectoQuantum2026 #BravectoSeizureWarning #FleaTickInjection1Year #IsoxazolineSafety #BravectoVsChews #patify
